Cross sections of the reaction 231 Pa(d,3n) 230 U for the production of 230 U/ 236 Th for targeted α therapy
230 U and its daughter nuclide 226 Th are novel therapeutic nuclides for application in targeted α therapy of cancer. We investigated the feasibility of producing 230 U/ 226 Th via deuteron irradiation of 231 Pa according to the reaction 231 Pa(d,3n) 230 U. The experimental excitation function for a deuteron-induced reaction on 231 Pa is reported for the first time. Cross sections were measured using thin targets of 231 Pa prepared by electrodeposition and 230 U yields were analysed using α spectrometry. Beam energies were calculated from measured beam orbits and compared with the values obtained via monitor reactions on aluminium foils using high-resolution γ spectrometry and IAEA recommended cross sections. Beam intensities were determined using a beam current integrator. The experimental cross sections are in excellent agreement with model calculations allowing for deuteron breakup using the EMPIRE 3 code. According to thick-target yields calculated from the experimental excitation function, the reaction 231 Pa(d,3n) 230 U allows the production of 230 U/ 226 Th at moderate levels.